ID:16045 Simultaneous Deep Brain Stimulation and Responsive Neurostimulation for Drug Refractory Epilepsy: A Case Report Study

Andres Restrepo, Rushna Ali,David Burdette, Andrew Zilgitt

Neuromodulation: Technology at the Neural Interface(2022)

Cited 0|Views1
No score
Abstract
Nearly 25% of all epilepsy is Drug Resistant Epilepsy (DRE) 1-3. Surgical evaluation should be considered early in the course of the disease to minimize morbidity and the risk of sudden unexpected death in epilepsy (SUDEP)4-5. Neuromodulation is a viable option when resection or ablation is not feasible. A growing body of evidence shows improved seizure control and long-term efficacy with both7. With highly complex epileptogenic networks, a multimodality approach may provide an additional benefit to maximize seizure control. We report two cases of DRE who underwent anterior nucleus of the thalamus (ANT) DBS implantation followed by RNS implantation. To our knowledge, this is the first report of simultaneous DBS and RNS neurostimulation for the treatment of epilepsy.
More
Translated text
Key words
drug refractory epilepsy,simultaneous deep brain stimulation,deep brain stimulation,responsive neurostimulation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined